Carducci MA - Search Results

1

Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial.

Phillips R, Shi WY, Deek M, Radwan N, Lim SJ, Antonarakis ES, Rowe SP, Ross AE, Gorin MA, Deville C, Greco SC, Wang H, Denmeade SR, Paller CJ, Dipasquale S, DeWeese TL, Song DY, Wang H, Carducci MA, Pienta KJ, Pomper MG, Dicker AP, Eisenberger MA, Alizadeh AA, Diehn M, Tran PT. Phillips R, et al. Among authors: carducci ma. JAMA Oncol. 2020 May 1;6(5):650-659. doi: 10.1001/jamaoncol.2020.0147. JAMA Oncol. 2020. PMID: 32215577 Free PMC article. Clinical Trial.

2

Interleukin-6: a candidate mediator of human prostate cancer morbidity.

Twillie DA, Eisenberger MA, Carducci MA, Hseih WS, Kim WY, Simons JW. Twillie DA, et al. Among authors: carducci ma. Urology. 1995 Mar;45(3):542-9. doi: 10.1016/S0090-4295(99)80034-X. Urology. 1995. PMID: 7879350

3

Prostate cancer treatment strategies based on tumor-specific biological principles: future directions.

Carducci MA, DeWeese TL, Nelson WG, Simons JW, Sinibaldi V, Eisenberger MA. Carducci MA, et al. Semin Oncol. 1996 Dec;23(6 Suppl 14):56-62. Semin Oncol. 1996. PMID: 8996587 Review.

4

Prostate-specific antigen and other markers of therapeutic response.

Carducci MA, DeWeese TL, Nelson JB. Carducci MA, et al. Urol Clin North Am. 1999 May;26(2):291-302, viii. doi: 10.1016/s0094-0143(05)70069-0. Urol Clin North Am. 1999. PMID: 10361552 Free article. Review.

5

Preliminary evaluation of a short course of estramustine phosphate and docetaxel (Taxotere) in the treatment of hormone-refractory prostate cancer.

Sinibaldi VJ, Carducci M, Laufer M, Eisenberger M. Sinibaldi VJ, et al. Semin Oncol. 1999 Oct;26(5 Suppl 17):45-8. Semin Oncol. 1999. PMID: 10604269 Clinical Trial.

6

Management of patients with rising prostate-specific antigen after radical prostatectomy.

Laufer M, Pound CR, Carducci MA, Eisenberger MA. Laufer M, et al. Among authors: carducci ma. Urology. 2000 Mar;55(3):309-15. doi: 10.1016/s0090-4295(99)00465-3. Urology. 2000. PMID: 10699599 Review. No abstract available.

7

Rapid disease progression after the administration of bicalutamide in patients with metastatic prostate cancer.

Laufer M, Sinibaldi VJ, Carducci MA, Eisenberger MA. Laufer M, et al. Among authors: carducci ma. Urology. 1999 Oct;54(4):745. doi: 10.1016/s0090-4295(99)00268-x. Urology. 1999. PMID: 10754148 Free article.

8

Complete androgen blockade for prostate cancer: what went wrong?

Laufer M, Denmeade SR, Sinibaldi VJ, Carducci MA, Eisenberger MA. Laufer M, et al. Among authors: carducci ma. J Urol. 2000 Jul;164(1):3-9. J Urol. 2000. PMID: 10840412 Free article. Review.

9

Identification and characterization of circulating prostate carcinoma cells.

Wang ZP, Eisenberger MA, Carducci MA, Partin AW, Scher HI, Ts'o PO. Wang ZP, et al. Among authors: carducci ma. Cancer. 2000 Jun 15;88(12):2787-95. doi: 10.1002/1097-0142(20000615)88:12<2787::aid-cncr18>3.0.co;2-2. Cancer. 2000. PMID: 10870062

10

Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy.

Roberts WW, Bergstralh EJ, Blute ML, Slezak JM, Carducci M, Han M, Epstein JI, Eisenberger MA, Walsh PC, Partin AW. Roberts WW, et al. Among authors: carducci m. Urology. 2001 Jun;57(6):1033-7. doi: 10.1016/s0090-4295(01)00978-5. Urology. 2001. PMID: 11377299

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

424 results

Search Page